Cargando…

Promising Immune Treatment of Advanced Cutaneous Squamous Cell Carcinoma with Cemiplimab—Real-World Experience in the Global SARS-CoV-2 Pandemic

Cutaneous squamous cell carcinoma (cSCC) is the second most frequent non-melanoma skin cancer. The standard curative treatment is surgical resection, but the treatment of locally advanced and metastatic disease apart from radiotherapy is currently based on cemiplimab. Cemiplimab has demonstrated eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pabianek, Marta, Lesiak, Aleksandra, Nejc, Dariusz, Kuncman, Łukasz, Narbutt, Joanna, Skibińska, Małgorzata, Ciążyńska, Magdalena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600858/ https://www.ncbi.nlm.nih.gov/pubmed/36290893 http://dx.doi.org/10.3390/curroncol29100616

Ejemplares similares

The role of inflammasomes in cutaneous pathology
por: Ciążyńska, Magdalena, et al.
Publicado: (2022)

Primary Merkel Cell Carcinoma: A Retrospective Analysis of 31 Cases in Poland
por: Ciążyńska, Magdalena, et al.
Publicado: (2020)

Risk Factors and Clinicopathological Features for Developing a Subsequent Primary Cutaneous Squamous and Basal Cell Carcinomas
por: Ciążyńska, Magdalena, et al.
Publicado: (2022)

COVID-19 in Patients with Atopic Dermatitis Treated with Dupilumab: Three Cases and a Literature Review
por: Ceryn, Justyna, et al.
Publicado: (2021)

Ultraviolet Radiation and Chronic Inflammation—Molecules and Mechanisms Involved in Skin Carcinogenesis: A Narrative Review
por: Ciążyńska, Magdalena, et al.
Publicado: (2021)

Alterations of the Skin and Gut Microbiome in Psoriasis and Psoriatic Arthritis
por: Olejniczak-Staruch, Irmina, et al.
Publicado: (2021)

The Role of NLRP1, NLRP3, and AIM2 Inflammasomes in Psoriasis: Review
por: Ciążyńska, Magdalena, et al.
Publicado: (2021)

Hippo Signaling Pathway as a New Potential Target in Non-Melanoma Skin Cancers: A Narrative Review
por: Bednarski, Igor Aleksander, et al.
Publicado: (2021)

Pros and cons of using systemic acitretin in the paediatric population
por: Sadowska, Magdalena, et al.
Publicado: (2020)

Effectiveness and safety of secukinumab in patients with moderate-to-severe plaque psoriasis – a real life retrospective study
por: Galica, Katarzyna, et al.
Publicado: (2020)

TaaI/Cdx-2 AA Variant of VDR Defines the Response to Phototherapy amongst Patients with Psoriasis
por: Lesiak, Aleksandra, et al.
Publicado: (2021)

Trends in basal cell carcinoma incidence rates: a 16-year retrospective study of a population in central Poland
por: Ciążyńska, Magdalena, et al.
Publicado: (2018)

Real-World Experience with Cemiplimab Treatment for Advanced Cutaneous Squamous Cell Carcinoma—A Retrospective Single-Center Study
por: Kuzmanovszki, Daniella, et al.
Publicado: (2023)

Case Series: Cemiplimab and Nivolumab Immunotherapy as Promising Treatment in Advanced or Metastatic Cutaneous Squamous Cell Carcinoma
por: Lai, Fei Ya, et al.
Publicado: (2023)

Off-label medications in the treatment of hospitalized children with atopic dermatitis
por: Niedźwiedź, Michał, et al.
Publicado: (2022)

Impact of the COVID-19 Pandemic on Atopic Dermatitis Patients
por: Sieniawska, Joanna, et al.
Publicado: (2022)

Cemiplimab and Cutaneous Squamous Cell Carcinoma: From Bench to Bedside
por: Goodman, D.T.
Publicado: (2022)

Rapid response to cemiplimab for advanced cutaneous squamous cell carcinoma
por: Zargham, Hanieh, et al.
Publicado: (2022)

Tumor of the Nose – A Rare Manifestation of a Metastatic Lung Cancer
por: Bolewska, Aleksandra, et al.
Publicado: (2021)

AntiTNF-alpha therapy normalizes levels of lipids and adipokines in psoriatic patients in the real-life settings
por: Olejniczak-Staruch, Irmina, et al.
Publicado: (2021)

Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients
por: Van Meerhaeghe, T., et al.
Publicado: (2022)

NLRP1 and NLRP3 inflammasomes as a new approach to skin carcinogenesis
por: Ciążyńska, Magdalena, et al.
Publicado: (2020)

Secukinumab for the Treatment of Psoriasis in Pediatrics: Patient Selection and Acceptability
por: Narbutt, Joanna, et al.
Publicado: (2023)

Trachyonychia successfully treated with low-dose acitretin in a paediatric patient
por: Siekierko, Aleksandra, et al.
Publicado: (2022)

Treatment of Unresectable Cutaneous Squamous Cell Carcinoma with Cemiplimab in a Patient on Dialysis
por: Grace de Lima, Stacy, et al.
Publicado: (2023)

Pemphigoid Gestationis – Case Report and Review of Literature
por: Ceryn, Justyna, et al.
Publicado: (2021)

The role of heterodimer IL-17-A/F in atopic dermatitis
por: Krzysiek, Joanna, et al.
Publicado: (2022)

Cemiplimab as First Line Therapy in Advanced Penile Squamous Cell Carcinoma: A Real-World Experience
por: Rouvinov, Keren, et al.
Publicado: (2023)

The incidence and clinical analysis of non-melanoma skin cancer
por: Ciążyńska, Magdalena, et al.
Publicado: (2021)

Author Correction: The incidence and clinical analysis of non‑melanoma skin cancer
por: Ciążyńska, Magdalena, et al.
Publicado: (2021)

UVB-induced bullous pemphigoid in a patient with psoriasis
por: Ceryn, Justyna, et al.
Publicado: (2020)

Cemiplimab in Ultra-Octogenarian Patients with Cutaneous Squamous Cell Carcinoma: The Real-Life Experience of a Tertiary Referral Center
por: Denaro, Nerina, et al.
Publicado: (2023)

Metastatic cutaneous squamous cell carcinoma responsive to cemiplimab in a patient with multiple myeloma
por: Marukian, Nareh Valerie, et al.
Publicado: (2020)

Cemiplimab for the Treatment of Advanced Cutaneous Squamous Cell Carcinoma: Appropriate Patient Selection and Perspectives
por: Mager, Layna, et al.
Publicado: (2023)

Efficacy of Cemiplimab in a Patient Affected by Cutaneous Squamous Cell Carcinoma and Myelodysplastic Syndrome
por: Proietti, Ilaria, et al.
Publicado: (2023)

Scalp metastases as the first sign of a breast carcinoma
por: Ciążyńska, Magdalena, et al.
Publicado: (2021)

Demodicosis as an opportunistic infection in a patient with Crohn’s disease treated with infliximab
por: Niedźwiedź, Michał, et al.
Publicado: (2022)

Cemiplimab for Locally Advanced and Metastatic Cutaneous Squamous-Cell Carcinomas: Real-Life Experience from the French CAREPI Study Group
por: Hober, Candice, et al.
Publicado: (2021)

Intravascular squamous cell carcinoma treated with cemiplimab
por: Rose, Alexander N., et al.
Publicado: (2021)

Identifying candidates for immunotherapy with cemiplimab to treat advanced cutaneous squamous cell carcinoma: an expert opinion
por: Argenziano, Giuseppe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s2jgdqvs7de7nfujo8ltbt6vb0